HOME Top Market Reports Metabolomics Market by Product (GC, HPLC, UPLC, NMR, Mass Spectrometry, Surface based mass analysis, Bioinformatics), Application (Biomarker & Drug Discovery, Nutrigenomics, Toxicology), Indication (Oncology, Cardiology, Inborn Errors) - Forecast to 2021

Metabolomics Market by Product (GC, HPLC, UPLC, NMR, Mass Spectrometry, Surface based mass analysis, Bioinformatics), Application (Biomarker & Drug Discovery, Nutrigenomics, Toxicology), Indication (Oncology, Cardiology, Inborn Errors) - Forecast to 2021

By: marketsandmarkets.com
Publishing Date: March 2017
Report Code: BT 2550

 

  Speak to Analyst Enquiry Before Buying Webinar
purchase report
download pdf  request for customisation


The global metabolomics market is estimated to grow at a CAGR of 14.6% from 2016 to 2021 to reach USD 2.39 Billion by 2021. The growth of the market can be attributed to factors such as the increasing need for accurate diagnosis of diseases, rising demand for personalized medicine, emergence of advanced technologies, increasing pharmaceutical and biotech R&D expenditure and the availability of government and private funding. However, the high cost of tools and instruments is one of the major factors that is expected to restrain market growth in the coming years.

In this report, the market is segmented on the basis of product & service, application and indication available in the metabolomics market. This report also provides market information on major regional segments, namely, North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.

The report provides an insight on the metabolomics product matrix which presents a comparative analysis of product portfolios of leading market players. Moreover, the vendor benchmarking provided in the report illustrates the comparison between the geographic and product strength of top companies.

The global metabolomics market is dominated by large market players such as Agilent Technologies, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Bruker Corporation (U.S.), Danaher Corporation (U.S.), Waters Corporation (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Shimadzu Corporation (Japan), Biocrates Life Sciences AG (Austria), Human Metabolome Technologies Inc. (Japan), LECO Corporation (U.S.), and Metabolon Inc. (U.S.). The leading players are continuously developing new and innovative products to maintain their shares in the metabolomics market.

Research Methodology

Top-down and bottom-up approaches were used to validate the size of the global metabolomics market and estimate the size of various other dependent submarkets. Major players in the market were identified through secondary research and their market revenues were determined through primary and secondary research. Secondary research included the study of the annual and financial reports of top market players, whereas primary research included extensive interviews with the key opinion leaders such as CEOs, directors, and marketing executives. The percentage splits, shares, and breakdowns of the product markets were determined using secondary sources and verified through primary sources. All possible parameters that affect the market covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. This data is consolidated and added to detailed inputs and analysis from MarketsandMarkets and presented in this report.

Metabolomics Market

To know about the assumptions considered for the study, download the pdf brochure

Target Audience

  • Metabolomics Instrumentation Technology Product Manufacturers
  • Researchers and Scientists
  • Metabolomics Industry Consulting Firms
  • Metabolomics Research and Development (R&D) Companies
  • Healthcare Institutions
  • Research Institutes
  • Market Research and Consulting Firms

Scope of the Report

This research report categorizes the global metabolomics market into the following segments and subsegments:

Global Metabolomics Market

  • Global Metabolomics Market, by Product & Service
    • Metabolomic Instruments
      • Separation Techniques
        • Gas Chromatography (GC)
        • Capillary Electrophoresis (CE)
        • High-performance Liquid Chromatography (HPLC)
        • Ultra-performance Liquid Chromatography (UPLC)
      • Detection Techniques
        • Nuclear Magnetic Resonance Spectroscopy (NMR)
        • Mass Spectrometry (MS)
        • Surface-based Mass Analysis
    • Metabolomic Bioinformatics Tools and Services
      • Bioinformatics Tools & Database
      • Bioinformatics Services
  • Global Metabolomics Market, by Application
    • Biomarker Discovery
    • Drug Discovery/Drug Assessment
    • Nutrigenomics
    • Toxicology Testing
    • Personalized Medicine
    • Functional Genomics
    • Other Applications
  • Global Metabolomics Market, by Indication
    • Cancer
    • Cardiovascular Disorders
    • Neurological disorders
    • Inborn Errors of Metabolism
    • Other Indications
  • Global Metabolomics Market, by Region
    • North America
      • U.S.
      • Canada
    • Europe
      • Germany
      • France
      • U.K.
      • Italy
      • Spain
      • Rest of Europe (RoE)
    • Asia-Pacific (APAC)
      • Japan
      • China
      • India
      • Rest of Asia-Pacific (RoAPAC)
    • Latin America
      • Brazil
      • Mexico
      • Rest of Latin America (RoLA)
    • Middle East and Africa

Available Customizations:

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

Product Analysis

  • Product matrix, which gives a detailed comparison of the product portfolios of each company

Geographic Analysis

  • Further breakdown of the Rest of Asia-Pacific metabolomics market in South Korea, Australia, New Zealand, and other countries

Company Information

  • Detailed analysis and profiling of additional market players (Up to 5)

Table of Contents

1 Introduction (Page No. - 25)
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Markets Covered
           1.3.2 Years Considered for the Study
    1.4 Currency
    1.5 Limitations
    1.6 Stakeholders

2 Research Methodology (Page No. - 29)
    2.1 Research Approach
           2.1.1 Secondary Research
                    2.1.1.1 Key Data From Secondary Sources
           2.1.2 Primary Research
                    2.1.2.1 Key Data From Primary Sources
                    2.1.2.2 Key Industry Insights
    2.2 Market Size Estimation
    2.3 Market Breakdown and Data Triangulation
    2.4 Market Share Estimation
    2.5 Assumptions for the Study

3 Executive Summary (Page No. - 36)

4 Premium Insights (Page No. - 47)
    4.1 Metabolomics Market Overview
    4.2 Asia-Pacific: Metabolomics Separation Tools Market, By Type
    4.3 Geographic Snapshot: Metabolomics Market
    4.4 Geographic Mix: Metabolomics Market
    4.5 Metabolomics Market: Developing vs Developed Markets

5 Market Overview (Page No. - 52)
    5.1 Introduction
    5.2 Market Dynamics
           5.2.1 Market Drivers
                    5.2.1.1 Availability of Government and Private Funding
                    5.2.1.2 Increasing Pharmaceutical and Biotech R&D Expenditure
                    5.2.1.3 Technological Advancements
                    5.2.1.4 Growing Demand for Personalized Medicine
                    5.2.1.5 Increasing Use of Metabolomics in Toxicology Testing
           5.2.2 Key Market Restraints
                    5.2.2.1 Issues Related to Data Examination and Processing
                    5.2.2.2 High Cost of Tools and Instruments
           5.2.3 Key Market Opportunities
                    5.2.3.1 Biomarker Development
                    5.2.3.2 Rapid Growth Opportunities in Emerging Markets
           5.2.4 Key Challenges
                    5.2.4.1 Complexity and Diversity of Biological Samples
                    5.2.4.2 Dearth of Skilled Researchers

6 Industry Insights (Page No. - 63)
    6.1 Introduction
    6.2 Industry Trends
           6.2.1 Increasing Adoption of Hyphenated Technologies
           6.2.2 Tie-Ups Between Instrument Manufacturers and Research Laboratories/Academic Institutions
    6.3 Regulatory Analysis

7 Technology Investment Potential (Page No. - 67)
    7.1 Introduction
    7.2 Investment Client Networks
    7.3 Funding Bodies/Initiatives (2012–2016)
    7.4 Analysis of Potential Areas for Technology Investment Using Strategic Evaluation
           7.4.1 Parameters Considered for Emerging Opportunity Evaluation
                    7.4.1.1 Level of Attractiveness
                    7.4.1.2 Probability of Success
           7.4.2 Opportunity Strategic Evaluation Analysis
           7.4.3 Description of Opportunities
                    7.4.3.1 Viable (Quadrant 1) – Biomarker Discovery and Lead Optimization in Drug Discovery
                               7.4.3.1.1 Biomarker Discovery
                               7.4.3.1.2 Lead Optimization in Drug Discovery
                               7.4.3.1.3 Toxicity Testing
                    7.4.3.2 Promising (Quadrant 2) – Companion Diagnostics for Personalized Medicine and Nutrigenomics
                               7.4.3.2.1 Companion Diagnostics for Personalized Medicine
                               7.4.3.2.2 Nutrigenomics
                               7.4.3.2.3 Agriculture
                    7.4.3.3 Challenging (Quadrant 3) – Environmental Metabolomics
                               7.4.3.3.1 Environmental Metabolomics
                               7.4.3.3.2 Functional Genomics

8 Global Metabolomics Market, By Product and Service (Page No. - 74)
    8.1 Introduction
    8.2 Metabolomics Instruments
           8.2.1 Separation Tools
                    8.2.1.1 High-Performance Liquid Chromatography
                    8.2.1.2 Gas Chromatography
                    8.2.1.3 Ultra-Performance Liquid Chromatography
                    8.2.1.4 Capillary Electrophoresis
           8.2.2 Detection Tools
                    8.2.2.1 Mass Spectrometry
                    8.2.2.2 Nuclear Magnetic Resonance Spectroscopy
                    8.2.2.3 Surface-Based Mass Analysis
    8.3 Metabolomics Bioinformatics Tools and Services
           8.3.1 Bioinformatics Tools & Databases
           8.3.2 Bioinformatics Services

9 Global Metabolomics Market, By Application (Page No. - 99)
    9.1 Introduction
    9.2 Biomarker Discovery
    9.3 Drug Discovery
    9.4 Toxicology Testing
    9.5 Nutrigenomics
    9.6 Functional Genomics
    9.7 Personalized Medicine
    9.8 Other Applications

10 Global Metabolomics Market, By Indication (Page No. - 111)
     10.1 Introduction
     10.2 Cancer
     10.3 Cardiovascular Disorders
     10.4 Neurological Disorders
     10.5 Inborn Errors of Metabolism
     10.6 Other Indications

11 Global Metabolomics Market, By Region (Page No. - 121)
     11.1 Introduction
     11.2 North America
             11.2.1 U.S.
             11.2.2 Canada
     11.3 Europe
             11.3.1 Germany
             11.3.2 U.K.
             11.3.3 France
             11.3.4 Italy
             11.3.5 Spain
             11.3.6 Rest of Europe
     11.4 Asia-Pacific
             11.4.1 Japan
             11.4.2 China
             11.4.3 India
             11.4.4 Rest of APAC
     11.5 Latin America
             11.5.1 Brazil
             11.5.2 Mexico
             11.5.3 Rest of Latin America
     11.6 Middle East and Africa

12 Competitive Landscape (Page No. - 199)
     12.1 Overview
     12.2 Product Portfolio Analysis
     12.3 Market Share Analysis
     12.4 Competitive Situations and Trends
             12.4.1 Product Launches and Enhancements
             12.4.2 Partnerships, Agreements, Collaborations, and Alliances
             12.4.3 Expansions
             12.4.4 Acquisitions and Divestitures

13 Company Profiles (Page No. - 207)
     13.1 Introduction
     13.2 Thermo Fisher Scientific Inc.
             13.2.1 Business Overview
             13.2.2 Products & Services Offered
             13.2.3 Recent Developments
             13.2.4 MnM View
     13.3 Agilent Technologies, Inc.
             13.3.1 Business Overview
             13.3.2 Products & Services Offered
             13.3.3 Recent Developments
             13.3.4 MnM View
     13.4 Waters Corporation
             13.4.1 Business Overview
             13.4.2 Products Offered
             13.4.3 Recent Developments
             13.4.4 MnM View
     13.5 Danaher Corporation
             13.5.1 Business Overview
             13.5.2 Products Offered
             13.5.3 Recent Developments
             13.5.4 MnM View
     13.6 Shimadzu Corporation
             13.6.1 Business Overview
             13.6.2 Products Offered
             13.6.3 Recent Developments
             13.6.4 MnM View
     13.7 Biocrates Life Sciences AG
             13.7.1 Business Overview
             13.7.2 Products Offered
             13.7.3 Recent Developments
     13.8 Bio-Rad Laboratories, Inc.
             13.8.1 Business Overview
             13.8.2 Products Offered
             13.8.3 Recent Developments
     13.9 Bruker Corporation
             13.9.1 Business Overview
             13.9.2 Products & Services Offered
             13.9.3 Recent Developments
     13.10 Human Metabolome Technologies, Inc.
             13.10.1 Business Overview
             13.10.2 Products Offered
             13.10.3 Recent Developments
     13.11 Leco Corporation
             13.11.1 Business Overview
             13.11.2 Products Offered
             13.11.3 Recent Developments
     13.12 Metabolon, Inc.
             13.12.1 Business Overview
             13.12.2 Products Offered
             13.12.3 Recent Developments

14 Appendix (Page No. - 259)
     14.1 Insights of Industry Experts
     14.2 Discussion Guide
     14.3 Other Developments
     14.4 Knowledge Store: Marketsandmarkets’ Subscription Portal
     14.5 Introducing RT: Real-Time Market Intelligence
     14.6 Available Customizations
     14.7 Related Reports


List of Tables (188 Tables)

Table 1 Global Metabolomics Market Snapshot
Table 2 Availability of Government and Private Funding to Drive the Market Growth
Table 3 Issues Related to Data Examination and Processing to Restrain Market Growth
Table 4 Biomarker Development to Offer Significant Opportunities for Market Growth
Table 5 Dearth of Skilled Researchers is A Major Challenge in the Market
Table 6 Regulatory Standard/Approval Required for Metabolomics Products, By Country/Region
Table 7 Global Metabolomics Market Size, By Product & Service, 2014–2021 (USD Million)
Table 8 Global Metabolomics Instruments Market Size, By Type, 2014–2021 (USD Million)
Table 9 Global Metabolomics Instruments Market Size, By Country, 2014–2021 (USD Million)
Table 10 Global Metabolomics Separation Tools Market Size, By Type, 2014–2021 (USD Million)
Table 11 Global Metabolomics Separation Tools Market Size, By Country, 2014–2021 (USD Million)
Table 12 Global High-Performance Liquid Chromatography Market Size, By Country, 2014–2021 (USD Million)
Table 13 Global Gas Chromatography Size, By Country, 2014–2021 (USD Million)
Table 14 Global Ultra-Performance Liquid Chromatography Market Size, By Country, 2014–2021 (USD Million)
Table 15 Global Capillary Electrophoresis Market Size, By Country, 2014–2021 (USD Million)
Table 16 Global Metabolomics Detection Tools Market Size, By Type, 2014–2021 (USD Million)
Table 17 Global Metabolomics Detection Tools Market Size, By Country, 2014–2021 (USD Million)
Table 18 Global Mass Spectrometry Market Size, By Country, 2014–2021 (USD Million)
Table 19 Global Nuclear Magnetic Resonance Spectroscopy Market Size, By Country, 2014–2021 (USD Million)
Table 20 Global Surface-Based Mass Analysis Market Size, By Country, 2014–2021 (USD Million)
Table 21 Global Metabolomics Bioinformatics Tools and Services Market Size, By Type, 2014–2021 (USD Million)
Table 22 Global Metabolomics Bioinformatics Tools and Services Market Size, By Country, 2014–2021 (USD Million)
Table 23 Global Bioinformatics Tools & Databases Market Size, By Country, 2014–2021 (USD Million)
Table 24 Global Bioinformatics Services Market Size, By Country, 2014–2021 (USD Million)
Table 25 Global Metabolomics Market Size, By Application, 2014–2021 (USD Million)
Table 26 Global Metabolomics Market Size for Biomarker Discovery Applications, By Country, 2014–2021 (USD Million)
Table 27 Global Metabolomics Market Size for Drug Discovery Applications, By Country, 2014–2021 (USD Million)
Table 28 Global Metabolomics Market Size for Toxicology Testing Applications, By Country, 2014-2021 (USD Million)
Table 29 Global Metabolomics Market Size for Nutrigenomic Applications, By Country, 2014-2021 (USD Million)
Table 30 Global Metabolomics Market Size for Functional Genomic Applications, By Country, 2014-2021 (USD Million)
Table 31 Global Metabolomics Market Size for Personalized Medicine Applications, By Country, 2014-2021 (USD Million)
Table 32 Global Metabolomics Market Size for Other Applications, By Country, 2014-2021 (USD Million)
Table 33 Global Metabolomics Market Size, By Indication, 2014–2021 (USD Million)
Table 34 Global Metabolomics Market Size for Cancer, By Country, 2014–2021 (USD Million)
Table 35 Global Metabolomics Market Size for Cardiovascular Disorders, By Country, 2014–2021 (USD Million)
Table 36 Global Metabolomics Market Size for Neurological Disorders, By Country, 2014-2021 (USD Million)
Table 37 Global Metabolomics Market Size for Inborn Errors of Metabolism, By Country, 2014-2021 (USD Million)
Table 38 Global Metabolomics Market Size for Other Indications, By Country, 2014-2021 (USD Million)
Table 39 Global Metabolomics Market Size, By Region, 2014–2021 (USD Million)
Table 40 North America: Metabolomics Market Size, By Country, 2014–2021 (USD Million)
Table 41 North America: Metabolomics Market Size, By Product & Service, 2014–2021 (USD Million)
Table 42 North America: Metabolomics Instruments Market Size, By Type, 2014–2021 (USD Million)
Table 43 North America: Metabolomics Instruments Market Size for Separation Tools, By Type, 2014–2021 (USD Million)
Table 44 North America: Metabolomics Instruments Market Size for Detection Tools, By Type, 2014–2021 (USD Million)
Table 45 North America: Metabolomics Bioinformatics Tools & Services Market Size, By Type, 2014–2021 (USD Million)
Table 46 North America: Metabolomics Market Size, By Application, 2014–2021 (USD Million)
Table 47 North America: Metabolomics Market Size, By Indication, 2014–2021 (USD Million)
Table 48 U.S.: Metabolomics Market Size, By Product & Service, 2014–2021 (USD Million)
Table 49 U.S.: Metabolomics Instruments Market Size, By Type, 2014–2021 (USD Million)
Table 50 U.S.: Metabolomics Instruments Market Size for Separation Tools, By Type, 2014–2021 (USD Million)
Table 51 U.S.: Metabolomics Instruments Market Size for Detection Tools, By Type, 2014–2021 (USD Million)
Table 52 U.S.: Metabolomics Bioinformatics Tools & Services Market Size, By Type, 2014–2021 (USD Million)
Table 53 U.S.: Metabolomics Market Size, By Application, 2014–2021 (USD Million)
Table 54 U.S.: Metabolomics Market Size, By Indication, 2014–2021 (USD Million)
Table 55 Canada: Metabolomics Market Size, By Product & Service, 2014–2021 (USD Million)
Table 56 Canada: Metabolomics Instruments Market Size, By Type, 2014–2021 (USD Million)
Table 57 Canada: Metabolomics Instruments Market Size for Separation Tools, By Type, 2014–2021 (USD Million)
Table 58 Canada: Metabolomics Instruments Market Size for Detection Tools, By Type, 2014–2021 (USD Million)
Table 59 Canada: Metabolomics Bioinformatics Tools & Services Market Size, By Type, 2014–2021 (USD Million)
Table 60 Canada: Metabolomics Market Size, By Application, 2014–2021 (USD Million)
Table 61 Canada: Metabolomics Market Size, By Indication, 2014–2021 (USD Million)
Table 62 Europe: Metabolomics Market Size, By Country, 2014–2021 (USD Million)
Table 63 Europe: Metabolomics Market Size, By Product & Service, 2014–2021 (USD Million)
Table 64 Europe: Metabolomics Instruments Market Size, By Type, 2014–2021 (USD Million)
Table 65 Europe: Metabolomics Instruments Market Size for Separation Tools, By Type, 2014–2021 (USD Million)
Table 66 Europe: Metabolomics Instruments Market Size for Detection Tools, By Type, 2014–2021 (USD Million)
Table 67 Europe: Metabolomics Bioinformatics Tools & Services Market Size, By Type, 2014–2021 (USD Million)
Table 68 Europe: Metabolomics Market Size, By Application, 2014–2021 (USD Million)
Table 69 Europe: Metabolomics Market Size, By Indication, 2014–2021 (USD Million)
Table 70 Germany: Metabolomics Market Size, By Product & Service, 2014–2021 (USD Million)
Table 71 Germany: Metabolomics Instruments Market Size, By Type, 2014–2021 (USD Million)
Table 72 Germany: Metabolomics Instruments Market Size for Separation Tools, By Type, 2014–2021 (USD Million)
Table 73 Germany: Metabolomics Instruments Market Size for Detection Tools, By Type, 2014–2021 (USD Million)
Table 74 Germany: Metabolomics Bioinformatics Tools & Services Market Size, By Type, 2014–2021 (USD Million)
Table 75 Germany: Metabolomics Market Size, By Application, 2014–2021 (USD Million)
Table 76 Germany: Metabolomics Market Size, By Indication, 2014–2021 (USD Million)
Table 77 U.K.: Metabolomics Market Size, By Product & Service, 2014–2021 (USD Million)
Table 78 U.K.: Metabolomics Instruments Market Size, By Type, 2014–2021 (USD Million)
Table 79 U.K.: Metabolomics Instruments Market Size for Separation Tools, By Type, 2014–2021 (USD Million)
Table 80 U.K.: Metabolomics Instruments Market Size for Detection Tools, By Type, 2014–2021 (USD Million)
Table 81 U.K.: Metabolomics Bioinformatics Tools & Services Market Size, By Type, 2014–2021 (USD Million)
Table 82 U.K.: Metabolomics Market Size, By Application, 2014–2021 (USD Million)
Table 83 U.K.: Metabolomics Market Size, By Indication, 2014–2021 (USD Million)
Table 84 France: Metabolomics Market Size, By Product & Service, 2014–2021 (USD Million)
Table 85 France: Metabolomics Instruments Market Size, By Type, 2014–2021 (USD Million)
Table 86 France: Metabolomics Instruments Market Size for Separation Tools, By Type, 2014–2021 (USD Million)
Table 87 France: Metabolomics Instruments Market Size for Detection Tools, By Type, 2014–2021 (USD Million)
Table 88 France: Metabolomics Bioinformatics Tools & Services Market Size, By Type, 2014–2021 (USD Million)
Table 89 France: Metabolomics Market Size, By Application, 2014–2021 (USD Million)
Table 90 France: Metabolomics Market Size, By Indication, 2014–2021 (USD Million)
Table 91 Italy: Metabolomics Market Size, By Product & Service, 2014–2021 (USD Million)
Table 92 Italy: Metabolomics Instruments Market Size, By Type, 2014–2021 (USD Million)
Table 93 Italy: Metabolomics Instruments Market Size for Separation Tools, By Type, 2014–2021 (USD Million)
Table 94 Italy: Metabolomics Instruments Market Size for Detection Tools, By Type, 2014–2021 (USD Million)
Table 95 Italy: Metabolomics Bioinformatics Tools & Services Market Size, By Type, 2014–2021 (USD Million)
Table 96 Italy: Market Size, By Application, 2014–2021 (USD Million)
Table 97 Italy: Metabolomics Market Size, By Indication, 2014–2021 (USD Million)
Table 98 Spain: Metabolomics Market Size, By Product & Service, 2014–2021 (USD Million)
Table 99 Spain: Metabolomics Instruments Market Size, By Type, 2014–2021 (USD Million)
Table 100 Spain: Metabolomics Instruments Market Size for Separation Tools, By Type, 2014–2021 (USD Million)
Table 101 Spain: Metabolomics Instruments Market Size for Detection Tools, By Type, 2014–2021 (USD Million)
Table 102 Spain: Metabolomics Bioinformatics Tools & Services Market Size, By Type, 2014–2021 (USD Million)
Table 103 Spain: Metabolomics Market Size, By Application, 2014–2021 (USD Million)
Table 104 Spain: Metabolomics Market Size, By Indication, 2014–2021 (USD Million)
Table 105 Rest of Europe: Metabolomics Market Size, By Product & Service, 2014–2021 (USD Million)
Table 106 RoE: Metabolomics Instruments Market Size, By Type, 2014–2021 (USD Million)
Table 107 RoE: Metabolomics Instruments Market Size for Separation Tools, By Type, 2014–2021 (USD Million)
Table 108 RoE: Metabolomics Instruments Market Size for Detection Tools, By Type, 2014–2021 (USD Million)
Table 109 RoE: Metabolomics Bioinformatics Tools & Services Market Size, By Type, 2014–2021 (USD Million)
Table 110 RoE: Metabolomics Market Size, By Application, 2014–2021 (USD Million)
Table 111 RoE: Metabolomics Market Size, By Indication, 2014–2021 (USD Million)
Table 112 Asia-Pacific: Metabolomics Market Size, By Country, 2014–2021 (USD Million)
Table 113 Asia-Pacific: Metabolomics Market Size, By Product & Service, 2014–2021 (USD Million)
Table 114 Asia-Pacific: Metabolomics Instruments Market Size, By Type, 2014–2021 (USD Million)
Table 115 Asia-Pacific: Metabolomics Instruments Market Size for Separation Tools, By Type, 2014–2021 (USD Million)
Table 116 Asia-Pacific: Metabolomics Instruments Market Size for Detection Tools, By Type, 2014–2021 (USD Million)
Table 117 Asia-Pacific: Metabolomics Bioinformatics Tools & Services Market Size, By Type, 2014–2021 (USD Million)
Table 118 Asia-Pacific: Metabolomics Market Size, By Application, 2014–2021 (USD Million)
Table 119 Asia-Pacific: Metabolomics Market Size, By Indication, 2014–2021 (USD Million)
Table 120 Japan: Metabolomics Market Size, By Product & Service, 2014–2021 (USD Million)
Table 121 Japan: Metabolomics Instruments Market Size, By Type, 2014–2021 (USD Million)
Table 122 Japan: Metabolomics Instruments Market Size for Separation Tools, By Type, 2014–2021 (USD Million)
Table 123 Japan: Metabolomics Instruments Market Size for Detection Tools, By Type, 2014–2021 (USD Million)
Table 124 Japan: Metabolomics Bioinformatics Tools & Services Market Size, By Type, 2014–2021 (USD Million)
Table 125 Japan: Metabolomics Market Size, By Application, 2014–2021 (USD Million)
Table 126 Japan: Metabolomics Market Size, By Indication, 2014–2021 (USD Million)
Table 127 China: Metabolomics Market Size, By Product & Service, 2014–2021 (USD Million)
Table 128 China: Metabolomics Instruments Market Size, By Type, 2014–2021 (USD Million)
Table 129 China: Metabolomics Instruments Market Size for Separation Tools, By Type, 2014–2021 (USD Million)
Table 130 China: Metabolomics Instruments Market Size for Detection Tools, By Type, 2014–2021 (USD Million)
Table 131 China: Metabolomics Bioinformatics Tools & Services Market Size, By Type, 2014–2021 (USD Million)
Table 132 China: Metabolomics Market Size, By Application, 2014–2021 (USD Million)
Table 133 China: Metabolomics Market Size, By Indication, 2014–2021 (USD Million)
Table 134 India: Metabolomics Market Size, By Product & Service, 2014–2021 (USD Million)
Table 135 India: Metabolomics Instruments Market Size, By Type, 2014–2021 (USD Million)
Table 136 India: Metabolomics Instruments Market Size for Separation Tools, By Type, 2014–2021 (USD Million)
Table 137 India: Metabolomics Instruments Market Size for Detection Tools, By Type, 2014–2021 (USD Million)
Table 138 India: Metabolomics Bioinformatics Tools & Services Market Size, By Type, 2014–2021 (USD Million)
Table 139 India: Metabolomics Market Size, By Application, 2014–2021 (USD Million)
Table 140 India: Metabolomics Market Size, By Indication, 2014–2021 (USD Million)
Table 141 RoAPAC: Metabolomics Market Size, By Product & Service, 2014–2021 (USD Million)
Table 142 RoAPAC: Metabolomics Instruments Market Size, By Type, 2014–2021 (USD Million)
Table 143 RoAPAC: Metabolomics Instruments Market Size for Separation Tools, By Type, 2014–2021 (USD Million)
Table 144 RoAPAC: Metabolomics Instruments Market Size for Detection Tools, By Type, 2014–2021 (USD Million)
Table 145 RoAPAC: Metabolomics Bioinformatics Tools & Services Market Size, By Type, 2014–2021 (USD Million)
Table 146 RoAPAC: Metabolomics Market Size, By Application, 2014–2021 (USD Million)
Table 147 RoAPAC: Metabolomics Market Size, By Indication, 2014–2021 (USD Million)
Table 148 Latin America: Metabolomics Market Size, By Country, 2014–2021 (USD Million)
Table 149 Latin America: Metabolomics Market Size, By Product & Service, 2014–2021 (USD Million)
Table 150 Latin America: Metabolomics Instruments Market Size, By Type, 2014–2021 (USD Million)
Table 151 Latin America: Metabolomics Instruments Market Size for Separation Tools, By Type, 2014–2021 (USD Million)
Table 152 Latin America: Metabolomics Instruments Market Size for Detection Tools, By Type, 2014–2021 (USD Million)
Table 153 Latin America: Metabolomics Bioinformatics Tools & Services Market Size, By Type, 2014–2021 (USD Million)
Table 154 Latin America: Metabolomics Market Size, By Application, 2014–2021 (USD Million)
Table 155 Latin America: Metabolomics Market Size, By Indication, 2014–2021 (USD Million)
Table 156 Brazil: Metabolomics Market Size, By Product & Service, 2014–2021 (USD Million)
Table 157 Brazil: Metabolomics Instruments Market Size, By Type, 2014–2021 (USD Million)
Table 158 Brazil: Metabolomics Instruments Market Size for Separation Tools, By Type, 2014–2021 (USD Million)
Table 159 Brazil: Metabolomics Instruments Market Size for Detection Tools, By Type, 2014–2021 (USD Million)
Table 160 Brazil: Metabolomics Bioinformatics Tools & Services Market Size, By Type, 2014–2021 (USD Million)
Table 161 Brazil: Metabolomics Market Size, By Application, 2014–2021 (USD Million)
Table 162 Brazil: Metabolomics Market Size, By Indication, 2014–2021 (USD Million)
Table 163 Mexico: Metabolomics Market Size, By Product & Service, 2014–2021 (USD Million)
Table 164 Mexico: Metabolomics Instruments Market Size, By Type, 2014–2021 (USD Million)
Table 165 Mexico: Metabolomics Instruments Market Size for Separation Tools, By Type, 2014–2021 (USD Million)
Table 166 Mexico: Metabolomics Instruments Market Size for Detection Tools, By Type, 2014–2021 (USD Million)
Table 167 Mexico: Metabolomics Market Size, By Application, 2014–2021 (USD Million)
Table 168 Mexico: Metabolomics Market Size, By Indication, 2014–2021 (USD Million)
Table 169 RoLA: Metabolomics Market Size, By Product & Service, 2014–2021 (USD Million)
Table 170 RoLA: Metabolomics Instruments Market Size, By Type, 2014–2021 (USD Million)
Table 171 RoLA: Metabolomics Instruments Market Size for Separation Tools, By Type, 2014–2021 (USD Million)
Table 172 RoLA: Metabolomics Instruments Market Size for Detection Tools, By Type, 2014–2021 (USD Million)
Table 173 RoLA: Metabolomics Bioinformatics Tools & Services Market Size, By Type, 2014–2021 (USD Million)
Table 174 RoLA: Metabolomics Market Size, By Application, 2014–2021 (USD Million)
Table 175 RoLA: Metabolomics Market Size, By Indication, 2014–2021 (USD Million)
Table 176 Middle East & Africa: Metabolomics Market Size, By Product & Service, 2014–2021 (USD Million)
Table 177 Middle East & Africa: Metabolomics Instruments Market Size, By Type, 2014–2021 (USD Million)
Table 178 Middle East & Africa: Metabolomics Instruments Market Size for Separation Tools, By Type, 2014–2021 (USD Million)
Table 179 Middle East & Africa: Metabolomics Instruments Market Size for Detection Tools, By Type, 2014–2021 (USD Million)
Table 180 Middle East & Africa: Metabolomics Bioinformatics Tools & Services Market Size, By Type, 2014–2021 (USD Million)
Table 181 Middle East & Africa: Metabolomics Market Size, By Application, 2014–2021 (USD Million)
Table 182 Middle East & Africa: Metabolomics Market Size, By Indication, 2014–2021 (USD Million)
Table 183 Growth Strategy Matrix (January 2013–November 2016)
Table 184 Product Portfolio Analysis: Metabolomics Market
Table 185 Product Launches and Enhancements, 2013–2016
Table 186 Partnerships, Agreements, Collaborations, and Alliances, 2013–2016
Table 187 Expansions, 2013–2016
Table 188 Acquisitions and Divestitures, 2013–2016


List of Figures (42 Figures)

Figure 1 Global Metabolomics Market
Figure 2 Research Design
Figure 3 Bottom-Up Approach
Figure 4 Top-Down Approach
Figure 5 Data Triangulation Methodology
Figure 6 Global Metabolomics Market, By Product & Service, 2016 vs 2021 (USD Million)
Figure 7 Global Metabolomics Instruments Market, By Type, 2016 vs 2021 (USD Million)
Figure 8 Global Metabolomics Separation Tools Market, By Type, 2016 vs 2021 (USD Million)
Figure 9 Global Metabolomics Detection Tools Market, By Type, 2016 vs 2021 (USD Million)
Figure 10 Global Metabolomics Market for Bioinformatics Tools and Services, By Type, 2016 vs 2021 (USD Million)
Figure 11 Global Metabolomics Market, By Application, 2016 vs 2021 (USD Million)
Figure 12 Global Metabolomics Market, By Indication, 2016 vs 2021 (USD Million)
Figure 13 Asia-Pacific to Register Highest Growth During the Forecast Period
Figure 14 Availability of Government and Private Funding for Research is Driving Growth of the Metabolomics Market
Figure 15 HPLC Commanded the Largest Share of the Asia-Pacific Metabolomics Separation Tools Market in 2015
Figure 16 U.S. Dominated the Global Metabolomics Market in 2015
Figure 17 Asia-Pacific to Register the Highest CAGR in the Forecast Period
Figure 18 Developing Markets to Register Higher Growth During the Forecast Period
Figure 19 Metabolomics Market: Drivers, Restraints, Opportunities, and Challenges
Figure 20 R&D Expenditure of Top Biotechnology and Pharmaceutical Companies, By Geography, 2012–2014
Figure 21 Global Metabolomics Market- Investment Client Network
Figure 22 Opportunity Strategic Evaluation Analysis of Metabolomics in Various Applications Areas
Figure 23 Metabolomics Instruments Dominated the Market in 2016
Figure 24 Biomarker Discovery to Dominate the Metabolomics Applications Market in 2016
Figure 25 Cancer Indication to Dominate the Market in 2016
Figure 26 Global Metabolomics Market: Geographical Snapshot
Figure 27 North America: Metabolomics Market Snapshot
Figure 28 Europe: Metabolomics Market Snapshot
Figure 29 Asia-Pacific: Metabolomics Market Snapshot
Figure 30 Key Developments in the Metabolomics Market, 2013–2016
Figure 31 Global Metabolomics Market Share Analysis, By Key Player, 2015
Figure 32 Battle for Market Share: Product Launches & Enhancements Was the Key Growth Strategy Adopted By Market Players
Figure 33 Geographic Revenue Mix of the Major Players in the Metabolomics Market
Figure 34 Thermo Fisher Scientific Inc.: Company Snapshot (2015)
Figure 35 Company Snapshot: Agilent Technologies, Inc.: (2015)
Figure 36 Waters Corporation: Company Snapshot (2015)
Figure 37 Danaher Corporation: Company Snapshot (2015)
Figure 38 Shimadzu Corporation: Company Snapshot (2015)
Figure 39 Bio-Rad Laboratories, Inc.: Company Snapshot (2015)
Figure 40 Bruker Corporation: Company Snapshot (2015)
Figure 41 Marketsandmarkets Knowledge Store Snapshot
Figure 42 Marketsandmarkets Knowledge Store: Healthcare Industry Snapshot

The global metabolomics market is estimated to reach USD 2.39 Billion by 2021, at a CAGR of 14.6% during the forecast period. The growing acceptance of metabolomics for personalized medicine, increasing pharmaceutical and biotech R&D expenditure, and continuous technological advancements are some of the factors driving market growth. New range of enhanced technologies for accuracy and precision in metabolomics research and growth in emerging markets due to increasing investments presents significant growth opportunities for players in the market. However, issues related to data examination and processing and high-cost tools and instruments and their maintenance are the major restraining factors for this market.

In this report, the metabolomics market is segmented on the basis of product & service, application, indication, and region. The research report discusses key market drivers, restraints, opportunities, and challenges in the global market and its submarkets. Based on product & service, the market is segmented into metabolomics instruments and metabolomics bioinformatics tools & services. The metabolomics instruments segment accounted for the largest share of the market in 2015. However, metabolomics bioinformatics tools & services is expected to grow at the highest CAGR during the forecast period. The ability of metabolome analysis software tools for interpreting the results of analytical experiments and understand the potential of metabolomics data generated from analytical tools are expected to drive the growth of this segment.

Based on application, the metabolomics market is segmented into biomarker discovery, drug discovery, nutrigenomics, toxicology testing, personalized medicine, functional genomics, and other applications. The biomarker discovery segment accounted for the largest share of the global metabolomics market in 2015. The large share of the biomarker discovery segment can be attributed to the rising incidence and prevalence of chronic diseases such as CVD, cancer, and diabetes; growing acceptance of cancer diagnostic tests; and scientific progression in discovery technologies.

In this report, the global metabolomics market has been studied at the regional and country levels. In 2015, North America represented the largest regional market, followed by Europe. North America will continue to dominate the market during the forecast period, the Asia-Pacific region is expected to register the highest growth. The growth of this regional segment is driven by the significant economic development in emerging markets, metabolomic technologies playing an integral role in the modern pharmaceutical and healthcare industries, and rising focus of key market players in this region.

Metabolomics Market

The major players in the global metabolomics market are Agilent Technologies, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Bruker Corporation (U.S.), Danaher Corporation (U.S.), Shimadzu Corporation (Japan), Metabolon Inc. (U.S.), LECO Corporation (U.S.), Biocrates Life Sciences AG (Austria), Human Metabolome Technologies, Inc. (Japan), and Waters Corporation (U.S.).

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit http://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement

Connect With Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441
UK : 44-800-368-9399

Search reports



Access reports on all high
growth Biotechnology Markets on KnowledgeStore
Request Demo